Drug Patents owned by Innocoll

1. Drug name - POSIMIR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11400019 INNOCOLL Sustained release drug delivery systems with reduced impurities and related methods
Jan, 2041

(18 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) Feb 1, 2024

Drugs and Companies using BUPIVACAINE ingredient

Market Authorisation Date: 01 February, 2021

Treatment: NA

Dosage: SOLUTION, EXTENDED RELEASE;INFILTRATION

More Information on Dosage
Strength Dosage Availability
660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE;INFILTRATION Prescription

availability in other generic markets.

Click on the highlighted region to filter.